Dianthus Therapeutics (DNTH) Other financing activities (2018 - 2024)

Dianthus Therapeutics' Other financing activities history runs 5 years deep, the most recent figure standing at $2.2 million for Q2 2024.

• In Q2 2024, Other financing activities changed N/A year-over-year to $2.2 million; the TTM figure through Mar 2025 stood at $2.2 million (down 81.94% YoY), while the FY2024 annual figure was $14.7 million, changed N/A from the prior year.
• Other financing activities was $2.2 million for Q2 2024 at Dianthus Therapeutics, down from $12.4 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $12.4 million in Q1 2024 to a low of $60000.0 in Q4 2020.
• Historically, Other financing activities has averaged $3.0 million across 3 years, with a median of $237000.0 in 2020.
• The sharpest annual moves came in 2020 and 2021: Other financing activities soared 46.3% in 2020, then slipped 6.33% in 2021.
• A 3-year view of Other financing activities shows it stood at $60000.0 in 2020, then soared by 270.0% to $222000.0 in 2021, then jumped by 910.36% to $2.2 million in 2024.
• The last three Other financing activities figures came in at $2.2 million (Q2 2024), $12.4 million (Q1 2024), and $222000.0 (Q3 2021), per Business Quant data.